LAVAL, QC and VAUGHAN, ON, May 5, 2022 /PRNewswire/ — Bausch + Lomb Corporation (“Bausch + Lomb”), a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), today announced the pricing of its initial public offering (“IPO”) of 35,000,000 common shares…